Southern Acids (M) Berhad Management

Management criteria checks 3/4

Southern Acids (M) Berhad's CEO is Nick Low, appointed in Jul 2015, has a tenure of 9.33 years. total yearly compensation is MYR941.88K, comprised of 54.4% salary and 45.6% bonuses, including company stock and options. directly owns 0.069% of the company’s shares, worth MYR292.18K. The average tenure of the management team and the board of directors is 11.1 years and 9.8 years respectively.

Key information

Nick Low

Chief executive officer

RM 941.9k

Total compensation

CEO salary percentage	54.4%
CEO tenure	9.3yrs
CEO ownership	0.07%
Management average tenure	11.1yrs
Board average tenure	9.8yrs

Recent management updates

Recent updates

Southern Acids (M) Berhad's (KLSE:SAB) Soft Earnings Are Actually Better Than They Appear

Mar 03

If You Like EPS Growth Then Check Out Southern Acids (M) Berhad (KLSE:SAB) Before It's Too Late

May 27

The Returns At Southern Acids (M) Berhad (KLSE:SAB) Aren't Growing

Apr 19

Are Strong Financial Prospects The Force That Is Driving The Momentum In Southern Acids (M) Berhad's KLSE:SAB) Stock?

Feb 24

Returns On Capital At Southern Acids (M) Berhad (KLSE:SAB) Paint An Interesting Picture

Jan 13

What Can We Learn About Southern Acids (M) Berhad's (KLSE:SAB) CEO Compensation?

Dec 15

Southern Acids (M) Berhad (KLSE:SAB) Share Prices Have Dropped 14% In The Last Three Years

Nov 24

CEO Compensation Analysis

How has Nick Low's remuneration changed compared to Southern Acids (M) Berhad's earnings?
Date	Total Compensation	Salary	Company Earnings
Jun 30 2024	n/a	n/a	RM 6m
Mar 31 2024	RM 942k	RM 512k	RM 14m
Dec 31 2023	n/a	n/a	-RM 1m
Sep 30 2023	n/a	n/a	RM 11m
Jun 30 2023	n/a	n/a	RM 28m
Mar 31 2023	RM 927k	RM 505k	RM 33m
Dec 31 2022	n/a	n/a	RM 69m
Sep 30 2022	n/a	n/a	RM 80m
Jun 30 2022	n/a	n/a	RM 86m
Mar 31 2022	RM 874k	RM 463k	RM 94m
Dec 31 2021	n/a	n/a	RM 74m
Sep 30 2021	n/a	n/a	RM 53m
Jun 30 2021	n/a	n/a	RM 44m
Mar 31 2021	RM 727k	RM 421k	RM 37m
Dec 31 2020	n/a	n/a	RM 40m
Sep 30 2020	n/a	n/a	RM 44m
Jun 30 2020	n/a	n/a	RM 44m
Mar 31 2020	RM 712k	RM 414k	RM 32m
Dec 31 2019	n/a	n/a	RM 24m
Sep 30 2019	n/a	n/a	RM 19m
Jun 30 2019	n/a	n/a	RM 19m
Mar 31 2019	RM 699k	RM 390k	RM 21m
Dec 31 2018	n/a	n/a	RM 29m
Sep 30 2018	n/a	n/a	RM 35m
Jun 30 2018	n/a	n/a	RM 32m
Mar 31 2018	RM 649k	RM 366k	RM 33m

Compensation vs Market: Nick's total compensation ($USD210.81K) is above average for companies of similar size in the MY market ($USD108.01K).

Compensation vs Earnings: Nick's compensation has been consistent with company performance over the past year.

CEO

Nick Low (45 yo)

9.3yrs

Tenure

RM 941,877

Compensation

Dr. Kok Thye Low , also known as Nick, has been Managing Director and Director of Southern Acids M Bhd since July 2015. Dr. Low served as a Director In-Lead of Oleochemical and Health Care Divisions at Sou...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Kok Low	MD & Non-Independent Executive Director	9.3yrs	RM 941.88k	0.069% MYR 292.2k
Kim Lim	Non-Independent Executive Director	16.3yrs	RM 759.05k	2.32% MYR 9.8m
Kee Cheong	Chief Financial Officer	11.1yrs	no data	no data
Thevakumar Kaliaperumal	General Manager of Operations	1.8yrs	no data	no data
Chuu Tiong	Chief Operating Officer of Oleochemical Manufacturing Segment	13.8yrs	no data	no data
Choon Chan	Chief Strategic Development Officer	no data	no data	no data
Kui Lim	Company Secretary	16.3yrs	no data	no data
Shu Ng	Company Secretary	1.7yrs	no data	no data

11.1yrs

Average Tenure

54.5yo

Average Age

Experienced Management: SAB's management team is seasoned and experienced (11.1 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Kok Low	MD & Non-Independent Executive Director	9.3yrs	RM 941.88k	0.069% MYR 292.2k
Kim Lim	Non-Independent Executive Director	19.3yrs	RM 759.05k	2.32% MYR 9.8m
Kin Chung	Non Independent Non Executive Director	12.7yrs	RM 150.45k	no data
Sulong bin Matjeraie	Independent Non-Executive Chairman	10.3yrs	RM 151.80k	no data
Yeng Wan	Independent & Non Executive Director	1.7yrs	RM 104.95k	no data
Deborah Choa	Independent Non-Executive Director	1.3yrs	RM 55.38k	no data

9.8yrs

Average Tenure

57yo

Average Age

Experienced Board: SAB's board of directors are considered experienced (9.8 years average tenure).

Southern Acids (M) Berhad Management

Management criteria checks 3/4

Key information

Recent management updates

Southern Acids (M) Berhad, Annual General Meeting, Aug 26, 2024

Southern Acids (M) Berhad Announces Redesignation of Chung Kin Mun from Independent Director to Non Independent and Non Executive Director

Southern Acids (M) Berhad Announces Redesignation of Stephen Wan Yeng Leong from Member of Audit Committee to Independent and Non Executive Chairman of Audit Committee

Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Independent and Non Executive Director

Southern Acids (M) Berhad, Annual General Meeting, Aug 30, 2023

Southern Acids (M) Berhad Announces Cessation of Office of Madam Leong So Seh as Member of Nomination and Remuneration Committee

Recent updates

New minor risk - Market cap size

Upcoming dividend of RM0.05 per share

New major risk - Revenue and earnings growth

Full year 2024 earnings released: EPS: RM0.10 (vs RM0.24 in FY 2023)

Southern Acids (M) Berhad, Annual General Meeting, Aug 26, 2024

New minor risk - Market cap size

Full year 2024 earnings released: EPS: RM0.10 (vs RM0.24 in FY 2023)

Southern Acids (M) Berhad Announces Redesignation of Chung Kin Mun from Independent Director to Non Independent and Non Executive Director

Third quarter 2024 earnings released: EPS: RM0.033 (vs RM0.12 in 3Q 2023)

Southern Acids (M) Berhad Announces Redesignation of Stephen Wan Yeng Leong from Member of Audit Committee to Independent and Non Executive Chairman of Audit Committee

Southern Acids (M) Berhad (KLSE:SAB) entered into agreement to acquire remaining 10% stake in Firstview Development Sdn Bhd from Low Mong Hua Sdn Berhad for RM 23.5 million.

Second quarter 2024 earnings released: RM0.039 loss per share (vs RM0.081 profit in 2Q 2023)

Upcoming dividend of RM0.05 per share at 1.5% yield

Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Independent and Non Executive Director

First quarter 2024 earnings released: EPS: RM0.067 (vs RM0.11 in 1Q 2023)

New minor risk - Market cap size

Full year 2023 earnings released: EPS: RM0.24 (vs RM0.69 in FY 2022)

Southern Acids (M) Berhad, Annual General Meeting, Aug 30, 2023

Southern Acids (M) Berhad Announces Cessation of Office of Madam Leong So Seh as Member of Nomination and Remuneration Committee

Full year 2023 earnings released: EPS: RM0.24 (vs RM0.69 in FY 2022)

Outhern Acids (M) Berhad Recommends Single Tier Final Dividend in Respect of the Financial Year Ended 31 March 2023

Southern Acids (M) Berhad's (KLSE:SAB) Soft Earnings Are Actually Better Than They Appear

Third quarter 2023 earnings released: EPS: RM0.12 (vs RM0.20 in 3Q 2022)

Second quarter 2023 earnings released: EPS: RM0.082 (vs RM0.13 in 2Q 2022)

Price target decreased to RM3.40

Insufficient new directors

Upcoming dividend of RM0.05 per share

Full year 2022 earnings released: EPS: RM0.69 (vs RM0.27 in FY 2021)

Southern Acids (M) Berhad Announces Final Dividend, Payable on 28 Nov. 2022

Southern Acids (M) Berhad Recommends Single Tier Final Dividend for the Financial Year Ended March 31, 2022

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to RM3.40

Insufficient new directors

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

First quarter 2022 earnings released: EPS RM0.17 (vs RM0.13 in 1Q 2021)

Upcoming dividend of RM0.05 per share

Full year 2021 earnings released: EPS RM0.27 (vs RM0.23 in FY 2020)

Price target decreased to RM3.40

Full year 2021 earnings released: EPS RM0.27 (vs RM0.23 in FY 2020)

If You Like EPS Growth Then Check Out Southern Acids (M) Berhad (KLSE:SAB) Before It's Too Late

Southern Acids (M) Berhad Recommends Final Dividend for the Year Ended March 31, 2021

The Returns At Southern Acids (M) Berhad (KLSE:SAB) Aren't Growing

Third quarter 2021 earnings released: EPS RM0.041 (vs RM0.076 in 3Q 2020)

Are Strong Financial Prospects The Force That Is Driving The Momentum In Southern Acids (M) Berhad's KLSE:SAB) Stock?

Returns On Capital At Southern Acids (M) Berhad (KLSE:SAB) Paint An Interesting Picture

What Can We Learn About Southern Acids (M) Berhad's (KLSE:SAB) CEO Compensation?

New 90-day high: RM3.88

Southern Acids (M) Berhad Announces Appointment of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Independent and Non Executive Ember of Audit Committee

Second quarter 2021 earnings released: EPS RM0.06

Southern Acids (M) Berhad (KLSE:SAB) Share Prices Have Dropped 14% In The Last Three Years

New 90-day high: RM3.80

Southern Acids (M) Berhad Announces the Resignation of Encik Teo Leng as Independent and Non Executive Member of Audit Committee

New 90-day high: RM3.72

Upcoming Dividend of RM0.05 Per Share

First quarter earnings released

New 90-day high - RM3.68

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age